Filters
reset all| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
RB1 testing for Retinoblastoma Impact Genetics Dynacare/LabCorp Canada | 3 | 2 |
|
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States | 97 | 77 |
|
Genetic testing in retinoblastoma Eye Cancer Genetics Universitätsklinikum Essen Germany | 2 | 1 |
|
Genetic Pathology SA Pathology Australia | 2 | 1 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
RB1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae United States | 409 | 164 |
|
Invitae United States | 160 | 62 |
|
Invitae 78 Gene Actionable Disorders Panel Invitae United States | 220 | 75 |
|
Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®) Ambry Genetics United States | 147 | 18 |
|
Variant Resolution Test for MelanomaNext® (+RNAinsight®) Ambry Genetics United States | 40 | 3 |
|
Variant Resolution Test for CancerNext-Expanded® (+RNAinsight®) Ambry Genetics United States | 95 | 71 |
|
PreventionGenetics, part of Exact Sciences United States | 78 | 64 |
|
RB1 gene sequence and deletion/duplication Ambry Genetics United States | 4 | 1 |
|
Ambry Genetics United States | 40 | 9 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.